While the MOLT-16 and LOUCY cell lines displayed a similar expression pattern of all three genes, BCL2L1 expression was consistently high in venetoclax-treated ALL-SIL cells. The gene discussed is BCL2L1; the disease is acute lymphoblastic leukemia.